Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group
Florian Strasser(University of St.Gallen), Thomas Cerny(University of Bern), Winfried Meißner(University Hospital Bonn), Gernot Ernst(University Hospital Bonn), Martin Schnelle(University Hospital Bonn), Marcus Reif(University Hospital Bonn), You-Dschun Ko(University Hospital Bonn), Thomas Ruhstaller(University Hospital Bonn), Kurt Possinger(University Hospital Bonn), Diana Lüftner(Sana Klinikum Lichtenberg)
Cited by 409
Related Papers
ESPEN guidelines on nutrition in cancer patients
|Clinical Nutrition|2016|3k
ESPEN practical guideline: Clinical Nutrition in cancer
|Clinical Nutrition|2021|1.4k
Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer
|British Journal of Cancer|1996|220
Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group
|Journal of Clinical Oncology|2011|190
Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide
|Annals of Oncology|2018|169